THE EU has approved the V-Go
Disposable Insulin Delivery Device
with a CE Mark.
The V-Go is a fully disposable
device designed to provide simple
basal-bolus therapy for adults who
require insulin therapy.
The device works by providing a
continuous preset basal rate of
insulin and allows for on-demand
bolus dosing around mealtimes
thereby providing an alternative to
taking multiple daily injections.The above article was sent to subscribers in Pharmacy Daily's issue from 26 Jul 11 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 26 Jul 11
STRONG growth in Australia has helped MedAdvisor Solutions achieve robust results for FY24, with a revenue increase of 24.6% on the previous corresponding period to $122.1 million.
WESFARMERS has today reported strong growth in revenue across its Health division and its Australian Pharmaceutical Industries (API) subsidiary, despite a significant reduction in COVID-19 anti-viral product sales.
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.